GenMark Diagnostics Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (23)

Latest Posts

About This Stock More About This Stock
Sideways Market Vexes Traders: Biotech Stocks Are Fading
Article By: Rod Raynovich
Sunday, March 10, 2019 5:05 AM EST
The 2019 rally is fading with few clues as to what comes next. The narrative gets more complicated once a slower global economic outlook gets factored into the fundamentals.
In this article: XLV, NITE, IBB, FBT, SPY, XBI, BIIB, IWM, GNMK, AMRN, TDOC
Read
Small Cap Biotechs Lead The Market In 2019 Up 20% YTD
Article By: Rod Raynovich
Thursday, February 28, 2019 12:20 PM EST
Gene Therapy stocks soar on Spark (ONCE) Deal: BLUE, CRSP, RARE; and XBI up 4.2%.
In this article: ONCE, RARE, DHR, GE, XBI, BLUE, CRSP, IWM, XLV, MRK, RHHBY, BMY, CELG, LOXO, LLY, GNMK, AMRN, TDOC
Read
GenMark Spikes After Guidance, Sees Eplex Revenue Up 270%
Article By: The Fly
Tuesday, January 8, 2019 4:14 PM EST
The company expects Q4 revenue of $19.4M, representing an increase of 21% over the fourth quarter of 2017.
In this article: GNMK
Read
Chart Of The Day - Genmark Diagnostics (GNMK)
Article By: Jim Van Meerten
Wednesday, January 15, 2014 10:17 AM EST
GNMK is a molecular diagnostics company focused on developing and commercializing its proprietary eSensor(R) detection technology. Since the Trend Spotter signaled a buy on 12/20 the stock gained 11.92%.
In this article: GNMK
Read

PARTNER HEADLINES

Latest Tweets for $GNMK

No tweets yet!